No Detail Found!

Conventional Weight-Based Versus Low-Dose Regimen of Heparin Administration to Achieve Target Activated Clotting Time on Cardiopulmonary Bypass in Pakistani Population

Author(s)
Musfireh Siddiqeh Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Wajahat Javed Mirza Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Javed Iqbal Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Imran Khan Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Ali R Mangi NIVID, Karachi, Pakistan
Muhammad Awais Dawood Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Qudsia Anjum Qureshi Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Afifa Mushtaq Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Abstract
Objective: To observe that whether target ACT values are achieved with conventional weight-calculated or low-dose heparin regimen during CPB in Pakistani Population undergoing elective Cardiac Surgery procedures. Methodology: The cross-sectional comparative study was conducted at Rawalpindi Institute of Cardiology, Department of Cardiac Surgery from 1st January 2019 to 1st January 2020. Three hundred thirty-six patients undergoing elective open-heart surgeries on CPB were included in this study. Patients receiving weight-based heparin dose were placed in Group-A, while those on lowdose heparin were placed in Group-B. ACT was considered to have reached the target value in range of 400-480 seconds, values between 481-1500 seconds were considered excessive, whereas ACT of >1500 was regarded as potentially highrisk for peri-operative bleeding . Results: 14.1% (n= 28) of Group-A patients achieved target ACT, whereas 58.3% (n=116) exceeded the target of 480. In 25.1% (n=50), ACT values were beyond the measuring capacity of the assay machine i.e. >1500. Only 2.5% (n=5) required additional dosage of heparin. Target ACT in Group B was achieved in 19.7% (n= 27), 55.5% (n=76) had excessive ACT values, whereas in 16.8% (n= 23), it was >1500. 9.5% (n=13) required an additional dosage of Heparin. Conclusion: In the Pakistani population, a target ACT can be achieved with a significantly lower dose than the conventional weight-based heparin dose. Larger studies, preferably randomized controlled trials are needed to determine the optimal heparin dose calculation for safe anti-coagulation during CPB.
Publication Details
Page(s) 34-37
Published Journal: Annals of the Pakistan Institute of Medical Sciences, Volume: 17, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Anticoagulation, Heparin, Clotting Time, Cardiopulmonary
0

Citations

0

Downloads

46

Views